About GNINE Bioceuticals
GNINE Bioceuticals is a company based in Karnal (India) founded in 2011. The company has 8 employees as of March 08, 2025. GNINE Bioceuticals offers products and services including Tablets and Injectables.
- Headquarter Karnal, India
- Employees 8 as on 08 Mar, 2025
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
- Legal Name G Nine Bioceuticals Pvt. Ltd
- Jurisdiction Karnal, Haryana, India
-
Annual Revenue
$2.17 M (USD)10.41as on Mar 31, 2024
-
Net Profit
$103.77 K (USD)3.98as on Mar 31, 2024
-
EBITDA
$205.19 K (USD)-8.64as on Mar 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
8
as on Mar 08, 2025
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of GNINE Bioceuticals
GNINE Bioceuticals offers a comprehensive portfolio of products and services, including Tablets and Injectables.
Tablets are manufactured for human and veterinary applications, primarily in the antibiotics sector.
Injectables are produced for both human and veterinary use, adhering to international quality standards.
Funding Insights of GNINE Bioceuticals
Detailed funding history for GNINE Bioceuticals
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by GNINE Bioceuticals
Investment portfolio details for GNINE Bioceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - GNINE Bioceuticals
Detailed financials for GNINE Bioceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Gnine Bioceuticals Comparisons
Peer comparison for GNINE Bioceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of GNINE Bioceuticals
Detailed competitors of GNINE Bioceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Gnine Bioceuticals
Complete news archive for GNINE Bioceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about GNINE Bioceuticals
GNINE Bioceuticals was founded in 2011.
GNINE Bioceuticals is headquartered in Karnal, India. It is registered at Karnal, Haryana, India.
As of Mar 08, 2025, the latest employee count at GNINE Bioceuticals is 8.
Annual revenue of GNINE Bioceuticals is $2.17M as on Mar 31, 2024.
GNINE Bioceuticals is identified as an ISO 9001-2015 certified entity that produces pharmaceutical formulations, with a specialization in antibiotics within the Beta Lactam section. It operates from a WHO-GMP compliant facility in Karnal, Haryana, India, which meets Schedule M standards and supports third-party manufacturing for various clients. Quality control is emphasized through advanced labs, and production includes tablets, dry syrups, and injectables for both human and veterinary markets, ensuring adherence to global norms and timely order fulfillment. This commitment to quality and care has been demonstrated over more than 25 years in the industry.
GNINE Bioceuticals offers Tablets and Injectables.